The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Cannabis does not interact with 2 cancer drugs

    Docetaxel (Taxotere) is used to treat breast cancer, while irinotecan (Camptosar) is used to treat cancer of the colon or rectum.

    This study shows that medicinal cannabis can be taken with both anticancer agents and does not require adjusting their doses.

    24 cancer patients were treated with injectable irinotecan or docetaxel followed 3 weeks later by the same drugs with medicinal cannabis (200 mL herbal tea, 1 gram per liter) for 15 consecutive days, starting 12 days before the second treatment.

    Medicinal cannabis had no influence on how the body handled either drug. The researchers concluded, “The evaluated variety of medicinal cannabis can be administered concomitantly with both anticancer agents without dose adjustments.”

    4/7/07 18:58 JR

    Leave a Comment

    You must be logged in to post a comment.